Nearly 20,000 Prostate Cancer Diagnoses Missed In England Because Of Covid-19 Pandemic

The Covid-19 pandemic has led to delays in diagnosing prostate cancer that in turn can significantly affect odds of survival and treatment options.

Source: Forbes.com Healthcare News - March 17, 2024 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news